Exhibit 107
Calculation of Filing Fee Table
FORM S-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
(Form Type)
Vitro Biopharma, Inc.
(Exact Name of Registrant As Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.001 | (1) | 1,957,845 | $ | (1) | $ | 176,206 | $0.00014760 | $ | 26.01 | |||||||||||||||||
Fees Previously Paid | (2) | (2) | - | - | - | 1,699.02 | ||||||||||||||||||||||
Total Offering Amounts | $ | 177,001.92 | $ | 26.01 | ||||||||||||||||||||||||
Total Fees Previously Paid | $ | - | $ | 1,699.02 | ||||||||||||||||||||||||
Total Fee Offsets | - | $ | 0.00 | |||||||||||||||||||||||||
Net Fees Due | $ | - | $ | 0.00 |
(1)
| Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(a) of the Securities Act. Given that there is no proposed maximum offering price per share of common stock, the registrant calculates the proposed maximum aggregate offering price, by analogy to Rule 457(f)(2), based on the book value of $0.09 per share of common stock the registrant registers, which was calculated from its unaudited balance sheet as of July 31, 2023. Given that the registrant’s shares of common stock are not traded on an exchange or over-the-counter, the registrant did not use the market prices of its common stock in accordance with Rule 457(c). | |
(2) | Previously Paid |